Empire Genomics - Enabling Personalized Medicine

New Products & Services

Empire Genomics (EG) is a molecular diagnostics company that develops and offers a comprehensive menu of assay services for use in diagnosing and guiding precise therapeutic treatments for patients. The EG services are designed to specifically meet the needs of pathologists, oncologists and researchers. Our mission is to address the problem the medical community faces with the rapid pace of molecular technology innovations, and the need for the delivery of clinically relevant, cost effective patient decision support tools. Ultimately, through our continued growth customers will be able to realize: faster and more effective drug development, lower healthcare costs, and better clinical outcomes for patients. Empire is uniquely positioned to bring this innovative service to the medical community through its highly qualified team, state of the art facilities and key strategic partnerships with leaders in the global research community. We are a resource to make personalized medicine a reality for you.

FISH Probes

Custom FISH probes, solid tumor probes, loci specific probes, and control probes.

Shop Now

BAC Clones

Empire Genomics offers its customers access to over one million BAC clones as either bacterial stabs or purified DNA.

Shop Now

Custom Services

Empire Genomics offers an assortment of custom services to meet your research or clinical needs.

Shop Now

Genotyping

SNP analysis services let you measure genetic variations.


Shop Now

Array CGH Services

Receive high-resolution evaluations of DNA copy number alterations associated with chromosome aberrations.

Shop Now

Circulating Tumor Cells

Easily count CTCs to determine the prognosis of patients with metastatic breast, colorectal or prostate cancer.

Shop Now

FISH Probes Manufactured

Scientific Citations

Recent News

Expression Of FGFR2b In Gastric Cancer As Measured By Immunohistochemistry With A Highly Specific Monoclonal Antibody

Gastric cancer is the second leading cause of death from cancer worldwide. Amplification of the FGFR2 oncogene has been reported in 3 to 9% of gastric...

Full Article


Prostate cancer risk locus at 8q24 as a regulatory hub by physical interactions with multiple genomic loci across the genome

Chromosome 8q24 locus contains regulatory variants that modulate genetic risk to various cancers including prostate cancer (PC). However, the biologic...

Full Article


Development and Characterization of a Novel Mouse Line Humanized for the Intestinal Peptide Transporter PEPT1

The proton-coupled oligopeptide transporter PEPT1 (SLC15A1) is abundantly expressed in the small intestine, but not colon, of mammals and found to med...

Full Article


view all news articles

Empire Genomics on Facebook Empire Genomics on Twitter Empire Genomics on LinkedIn Empire Genomics on Google+